Pudexacianinium (ASP5354) chloride for ureter visualization in participants undergoing laparoscopic, minimally invasive colorectal surgery.

Journal Information

Full Title: Surg Endosc

Abbreviation: Surg Endosc

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Diagnostic Imaging

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"table 3 ). all data"

Code Sharing
Evidence found in paper:

"Declarations DisclosuresDr. Matthew Albert received consulting fees/research support from Astellas; Dr. Pauline Gerritsen-van Schieveen, Dr. Na Cai, Dr. Jeffrey Raizer, and Ms. Leticia Delgado-Herrera were employees of Astellas at the time of the study; Dr. Shin Takusagawa and Mr. Tomoyoshi Kishimoto are employees/stockholders of Astellas. Ms. Leticia Delgado-Herrera and Dr. Shin Takusagawa have a patent pending for pharmaceutical composition for imaging; Mr. John Fengler is an employee/stockholder and has patents planned, issued, or pending with Stryker; Dr. Jennifer Paruch has no conflicts of interest or financial ties to disclose. Disclosures Dr. Matthew Albert received consulting fees/research support from Astellas; Dr. Pauline Gerritsen-van Schieveen, Dr. Na Cai, Dr. Jeffrey Raizer, and Ms. Leticia Delgado-Herrera were employees of Astellas at the time of the study; Dr. Shin Takusagawa and Mr. Tomoyoshi Kishimoto are employees/stockholders of Astellas. Ms. Leticia Delgado-Herrera and Dr. Shin Takusagawa have a patent pending for pharmaceutical composition for imaging; Mr. John Fengler is an employee/stockholder and has patents planned, issued, or pending with Stryker; Dr. Jennifer Paruch has no conflicts of interest or financial ties to disclose."

Evidence found in paper:

"Funding This study was funded by Astellas Pharma, Inc."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025